An Open-label Extension Study of Oral Treprostinil in Su

Project: Research project

Project Details

Description

An Open-label Extension Study of Oral Treprostinil in Subjects with Pulmonary Hypertension (PH) Associated with Heart Failure with Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
StatusFinished
Effective start/end date10/1/1711/14/19

Funding

  • United Therapeutics Corporation

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.